- Report
- October 2024
- 186 Pages
Global
From €3382EUR$3,545USD£2,833GBP
€3758EUR$3,939USD£3,148GBP
- Report
- August 2023
- 114 Pages
Global
From €3500EUR$3,930USD£3,034GBP
Addison Disease Testing is a diagnostic test used to detect the presence of Addison Disease, an endocrine disorder caused by the body's inability to produce enough of the hormones cortisol and aldosterone. The test is typically performed by measuring the levels of cortisol and aldosterone in the blood, urine, or saliva. It may also include imaging tests such as CT scans or MRI scans.
The Addison Disease Testing market is a growing segment of the diagnostics industry, as the prevalence of the disease is increasing. The market is driven by the increasing awareness of the disease, the availability of advanced diagnostic technologies, and the rising demand for early diagnosis and treatment.
Some of the major players in the Addison Disease Testing market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Bio-Rad Laboratories, and Quest Diagnostics. Show Less Read more